The insulin-like growth factor binding protein BP-25 is expressed by human breast cancer cells

D. Yee, R. E. Favoni, R. Lupu, K. J. Cullen, G. S. Lebovic, K. K. Huff, Phillip Lee, Y. L. Lee, D. R. Powell, R. B. Dickson, N. Rosen, M. E. Lippman

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Specific binding proteins are thought to modulate the effects of IGF-I. Previous work has demonstrated that media conditioned by human breast cancer cells contains IGF-I binding activity. Radiolabelled IGF-I incubated with serum-free conditioned media from the breast cancer cell line MDA-MB 231 eluted with an apparent M.W. of 35-40 kDa when analyzed by gel filtration chromatography at pH 7.4. The M.W. of this binding activity corresponded to that of BP-25, a binding protein cloned from the hepatocellular carcinoma cell line HepG2. Two breast cancer cell lines, MDA-MB 231 and Hs578T, were found to express BP-25 RNA. Specific BP-25 radioimmunoassay detected BP-25 production in the conditioned media of these two cell lines. Immunoprecipitation confirmed that metabolically labelled MDA-MB 231 released 30 kDa BP-25 into its medium. This study demonstrates that some breast cancer cells express the IGF-I binding protein, BP-25.

Original languageEnglish (US)
Pages (from-to)38-44
Number of pages7
JournalBiochemical and Biophysical Research Communications
Volume158
Issue number1
DOIs
StatePublished - Jan 16 1989
Externally publishedYes

Fingerprint

Insulin-Like Growth Factor Binding Proteins
Insulin-Like Growth Factor I
Conditioned Culture Medium
Cells
Breast Neoplasms
Cell Line
Carrier Proteins
Serum-Free Culture Media
Immunoprecipitation
Radioimmunoassay
Gel Chromatography
Hepatocellular Carcinoma
RNA
Chromatography
Gels

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

The insulin-like growth factor binding protein BP-25 is expressed by human breast cancer cells. / Yee, D.; Favoni, R. E.; Lupu, R.; Cullen, K. J.; Lebovic, G. S.; Huff, K. K.; Lee, Phillip; Lee, Y. L.; Powell, D. R.; Dickson, R. B.; Rosen, N.; Lippman, M. E.

In: Biochemical and Biophysical Research Communications, Vol. 158, No. 1, 16.01.1989, p. 38-44.

Research output: Contribution to journalArticle

Yee, D, Favoni, RE, Lupu, R, Cullen, KJ, Lebovic, GS, Huff, KK, Lee, P, Lee, YL, Powell, DR, Dickson, RB, Rosen, N & Lippman, ME 1989, 'The insulin-like growth factor binding protein BP-25 is expressed by human breast cancer cells', Biochemical and Biophysical Research Communications, vol. 158, no. 1, pp. 38-44. https://doi.org/10.1016/S0006-291X(89)80173-1
Yee, D. ; Favoni, R. E. ; Lupu, R. ; Cullen, K. J. ; Lebovic, G. S. ; Huff, K. K. ; Lee, Phillip ; Lee, Y. L. ; Powell, D. R. ; Dickson, R. B. ; Rosen, N. ; Lippman, M. E. / The insulin-like growth factor binding protein BP-25 is expressed by human breast cancer cells. In: Biochemical and Biophysical Research Communications. 1989 ; Vol. 158, No. 1. pp. 38-44.
@article{f5ad12dc6e36435ab214e2208ef076e2,
title = "The insulin-like growth factor binding protein BP-25 is expressed by human breast cancer cells",
abstract = "Specific binding proteins are thought to modulate the effects of IGF-I. Previous work has demonstrated that media conditioned by human breast cancer cells contains IGF-I binding activity. Radiolabelled IGF-I incubated with serum-free conditioned media from the breast cancer cell line MDA-MB 231 eluted with an apparent M.W. of 35-40 kDa when analyzed by gel filtration chromatography at pH 7.4. The M.W. of this binding activity corresponded to that of BP-25, a binding protein cloned from the hepatocellular carcinoma cell line HepG2. Two breast cancer cell lines, MDA-MB 231 and Hs578T, were found to express BP-25 RNA. Specific BP-25 radioimmunoassay detected BP-25 production in the conditioned media of these two cell lines. Immunoprecipitation confirmed that metabolically labelled MDA-MB 231 released 30 kDa BP-25 into its medium. This study demonstrates that some breast cancer cells express the IGF-I binding protein, BP-25.",
author = "D. Yee and Favoni, {R. E.} and R. Lupu and Cullen, {K. J.} and Lebovic, {G. S.} and Huff, {K. K.} and Phillip Lee and Lee, {Y. L.} and Powell, {D. R.} and Dickson, {R. B.} and N. Rosen and Lippman, {M. E.}",
year = "1989",
month = "1",
day = "16",
doi = "10.1016/S0006-291X(89)80173-1",
language = "English (US)",
volume = "158",
pages = "38--44",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - The insulin-like growth factor binding protein BP-25 is expressed by human breast cancer cells

AU - Yee, D.

AU - Favoni, R. E.

AU - Lupu, R.

AU - Cullen, K. J.

AU - Lebovic, G. S.

AU - Huff, K. K.

AU - Lee, Phillip

AU - Lee, Y. L.

AU - Powell, D. R.

AU - Dickson, R. B.

AU - Rosen, N.

AU - Lippman, M. E.

PY - 1989/1/16

Y1 - 1989/1/16

N2 - Specific binding proteins are thought to modulate the effects of IGF-I. Previous work has demonstrated that media conditioned by human breast cancer cells contains IGF-I binding activity. Radiolabelled IGF-I incubated with serum-free conditioned media from the breast cancer cell line MDA-MB 231 eluted with an apparent M.W. of 35-40 kDa when analyzed by gel filtration chromatography at pH 7.4. The M.W. of this binding activity corresponded to that of BP-25, a binding protein cloned from the hepatocellular carcinoma cell line HepG2. Two breast cancer cell lines, MDA-MB 231 and Hs578T, were found to express BP-25 RNA. Specific BP-25 radioimmunoassay detected BP-25 production in the conditioned media of these two cell lines. Immunoprecipitation confirmed that metabolically labelled MDA-MB 231 released 30 kDa BP-25 into its medium. This study demonstrates that some breast cancer cells express the IGF-I binding protein, BP-25.

AB - Specific binding proteins are thought to modulate the effects of IGF-I. Previous work has demonstrated that media conditioned by human breast cancer cells contains IGF-I binding activity. Radiolabelled IGF-I incubated with serum-free conditioned media from the breast cancer cell line MDA-MB 231 eluted with an apparent M.W. of 35-40 kDa when analyzed by gel filtration chromatography at pH 7.4. The M.W. of this binding activity corresponded to that of BP-25, a binding protein cloned from the hepatocellular carcinoma cell line HepG2. Two breast cancer cell lines, MDA-MB 231 and Hs578T, were found to express BP-25 RNA. Specific BP-25 radioimmunoassay detected BP-25 production in the conditioned media of these two cell lines. Immunoprecipitation confirmed that metabolically labelled MDA-MB 231 released 30 kDa BP-25 into its medium. This study demonstrates that some breast cancer cells express the IGF-I binding protein, BP-25.

UR - http://www.scopus.com/inward/record.url?scp=0024489917&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024489917&partnerID=8YFLogxK

U2 - 10.1016/S0006-291X(89)80173-1

DO - 10.1016/S0006-291X(89)80173-1

M3 - Article

VL - 158

SP - 38

EP - 44

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 1

ER -